Alopexx Secures Investment from Biotech Consortia to Advance Broad-Spectrum Antimicrobial Vaccine AV0328
Alopexx, Inc. has received investment from Biotech Consortia, Inc. to support the development and commercialization of its antimicrobial vaccine, AV0328.
© Copyright 2025. All Rights Reserved by MedPath